Completed PHASE1 INTERVENTIONAL 2-arm
NCT07256600
PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence After Administration of DWJ1445 and DWC202506 in Healthy Adults
Sponsor: Daewoong Pharmaceutical Co. LTD.
Conditions
Healthy Subjects
Updated 1 time since 2026 Last updated: Dec 2, 2025 Started: Nov 14, 2025 Primary completion: Nov 23, 2025 Completion: Dec 2, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07256600, this PHASE1 trial focuses on Healthy Subjects and remains completed. Sponsored by Daewoong Pharmaceutical Co. LTD., it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Daewoong Pharmaceutical Co. LTD.
Data source: Daewoong Pharmaceutical Co. LTD.
For direct contact, visit the study record on ClinicalTrials.gov .